QUVIVIQ
Idorsia Pharmaceuticals Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79350361 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2022-07-06 | Application Filed |
| 2022-09-22 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-09-22 | Status: Live/Pending |
| 2022-09-23 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Idorsia Pharmaceuticals Ltd |
| Address | Hegenheimermattweg 91 CH-4123 Allschwil CH |
| Legal Entity Type | Aktiengesellschaft (ag) |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergy diseases, autoimmune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, central nervous system diseases and disorders, dementia, insomnia, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage diseases, Fabry disease and Fabry disease symptoms and sequela, infectious diseases and cancer |
| DM0000 | The mark consists of the stylized wording "QUVIVIQ" with five circles formingan arch over the "VIV" letters in the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-09-22 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-09-23 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-09-27 | 3 MAFR O:Outgoing Correspondence |
| CORRECTION TRANSACTION RECEIVED FROM IB | 2023-02-13 | 4 CRCV M: |
| CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | 2023-03-02 | 5 CORR I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2023-04-20 | 6 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-04-26 | 7 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-04-27 | 8 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-06-10 | 9 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-06-10 | 10 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-07-04 | 11 RFNT P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-12-07 | 12 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-12-07 | 13 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-12-07 | 14 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-12-07 | 15 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-12-07 | 16 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-12-07 | 17 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-12-07 | 18 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-12-07 | 19 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-12-08 | 20 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-12-11 | 21 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-12-27 | 22 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-12-27 | 23 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-12-27 | 24 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2024-01-13 | 25 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2024-01-16 | 26 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-01-16 | 27 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-04-02 | 28 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-04-02 | 29 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-07-03 | 30 FICR P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 QUVIVIQ 79350361 not registered Live/Pending |
Idorsia Pharmaceuticals Ltd 2022-07-06 |
 QUVIVIQ 79299719 not registered Live/Pending |
Idorsia Pharmaceuticals Ltd 2020-10-08 |
 QUVIVIQ 79274313 not registered Live/Pending |
Idorsia Pharmaceuticals Ltd. 2019-11-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 